Brokerage rep called back laughing. Asked if I was aware I had GTC sell orders pending at $1.80, $1.87, $1.92 and $1.95 from my buying spree last week.
That's a euphemism. Vancouver Energy terminal is being put in a nursing home to die like the Keystone XL pipeline. Opposition is too local, too concentrated and too invested in the outcome.
Most compensation plans include fixed cash and at-risk components (cash, stock or both), but the value and proportion of each (i.e., the pay mix) typically is established to be market -competitive for similar positions in companies of comparable stature (i.e. assets, revenue, net income, etc.). The at-risk components may be short-term (cash) or long-term (equity) incentives.
Stock options, restricted stock, phantom stock and stock appreciation rights, collectively known as equity compensation, are common long-term incentives for executives to achieve group and/or individual performance objectives. Key employees (typically managers and professionals) also may be designated as participants in equity compensation plans.
Standard sales compensation components are salary, commission, bonus and sales incentives (typically non-monetary awards, such as trips or gifts).
The strike price of stock options must be set at fair market value according to IRS rules on the date of the grant. Exercise (vesting) dates are determined by a plan schedule intended to secure the recipient's service over time or to promote achievement of certain performance goals or market share price. Expiration dates most commonly are ten years post-grant or upon termination of employment, immediately for non-vested options and within a short period of time thereafter for vested options.
Clarification required. Looked back at jetbpc's message and he just said MU was interesting due to hedge fund positions but did not see it moving until later this year. Suggested this summer may be a good time to start a position.
Congratulations. What do you see ahead for MU? Is it time to go long? jetbpc had suggested looking into it for some summer action. Maybe he will chime in, too.
Yikes! That's enough shares and under such circumstances a major holder surely is involved. Wilder was supposed to purchase his $40M on the open market, but perhaps he made a deal with someone (not necessarily on the board). Guess we may have to wait up to ten days to find out, but such a transaction could explain the last-minute cliff-dive if someone or someone's computer detected it. Donning my houndstooth hat to investigate. Please report if you see something.
Wow, I suspected something like this when the bottom fell out of the share price. Critical loss, Di Russo was the linchpin for all clinical trials. Says he has been at Pfizer since May. CTSO owed us an 8-K within four business days.
The proxy statement also indicates the additional shares could be used to consummate a merger or acquisition as well as to serve as a poison pill. Didn't Wilder say something about having freedom to do whatever it takes to turn around XCO?
The only one I could find in a cursory search was Blackrock's ETF mister_luckee mentioned in his post below. Perusing that fund's health care sector holdings in CTSO's current share price range, the fund may purchase only 50k -100k shares.
The index reconstitution is not effective until June 26. The reduction in CTSO's market cap since March is closer to 60% and may have cost inclusion in the Russell 3000. The current market cap at $152M still is within the range of $30M - $884M for the 1633 companies included in the Micro-Cap index. Just FYI, the weighted average market cap for the index is $419M and the median $219M, so it would seem CTSO has a plenty of company in the low end of the range and, barring disastrous developments, would not appear to be in danger of being dropped at the next reconstitution.
OPEC trying to put the damper on persistent strength in shale crude production. Didn't account for the best shale producers' ability to cut costs and increase efficiency.
Can't answer for vlono.1fan, but Blake Fernandez at Scotia Howard Weil publishes a "Weekly Refining Indicators Report" that captures a whole lot of data related to US petroleum refining. You can just search what I included in quotation marks to find the latest report.
$327M doesn't seem like much, but no telling how the market reacts to yet another prospect of a Greek default. History and current developments are on dfscorner's side from a trading perspective. Sometimes the market seems to be looking for an excuse. Watching for a possible Monday morning foray into SH, VXX, TLT or TLH myself, if the stampede is not already underway.
'Those who cannot remember the past are condemned to repeat it.' (George Santayana). Kirkman's still is in the saddle, and remind me how long it has been since ONTY (back to Biomira days) has commercialized a product. Would not be surprised if ASCO presentation is not much more than a reiteration of ONT-380 results reported in December, like Kirkman did many times with Stimuvax.